Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05864144
Title A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sensei Biotherapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Hematology/Oncology RECRUITING Los Angeles California 90095 United States Details
University of Colorado Cancer Center - Anschutz Medical NOT_YET_RECRUITING Aurora Colorado 80045 United States Details
Norton Healthcare RECRUITING Louisville Kentucky 40202 United States Details
Henry Ford Cancer NOT_YET_RECRUITING Detroit Michigan 48202 United States Details
Icahn School of Medicine at Mt. Sinai RECRUITING New York New York 10029 United States Details
University of Pennsylvania, Perelman Center for Advanced Medicine RECRUITING Philadelphia Pennsylvania 19104 United States Details
UPMC Hillman Cancer Center WITHDRAWN Pittsburgh Pennsylvania 15232 United States Details
Sanford Cancer Center RECRUITING Sioux Falls South Dakota 57104 United States Details
NEXT Oncology Dallas RECRUITING Irving Texas 75039 United States Details
South Texas Accelerated Research Therapeutics (START) San Antonio RECRUITING San Antonio Texas 78229 United States Details
START Mountain Region RECRUITING West Valley City Utah 84119 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field